Clinical manifestations are complex and often involve multi-systematic stress. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnostic and therapeutic programs. Treatment and management of antissynthetic syndrome associated with joint pain requires individual development, usually including pharmacotherapy, rehabilitation intervention, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely regimens according to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of joint pain associated with synthetase syndrome. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.